APTV vs BABA

The deterministic health scores present a mixed picture: the Piotroski F-Score of 4/9 indicates stable but not strong financial health, while the absence of an Altman Z-Score prevents a full distress risk assessment. Despite a high current P/E of 58.82, the forward P/E of 9.01 suggests strong earnings growth expectations. The company beats earnings estimates consistently, with a 3/4 beat rate over the last four quarters and an average surprise of 14.89%, yet insider selling and weak long-term price performance raise caution. While analysts are bullish with a $101.81 target price and a 'buy' recommendation, the stock trades at a significant premium to the Graham Number of $35.41, implying high valuation risk.

The Advanced Deterministic Scorecard reveals a mixed financial profile for Alibaba (BABA), with a weak Piotroski F-Score of 4/9 indicating suboptimal financial health, and no available Altman Z-Score limiting distress risk assessment. While valuation metrics appear favorable relative to peers—especially a Price/Sales of 0.41 and Forward P/E of 19.50—earnings growth is sharply negative (YoY EPS down 71%), and recent quarterly beats have reversed into consistent misses over the last four quarters. Strong insider sentiment and a bullish analyst consensus (strong_buy) contrast with deteriorating profitability and weak technical trends (10/100). The stock trades significantly above the Graham Number ($102.68) and intrinsic value estimate ($51.38), suggesting overvaluation unless growth rebounds materially.